IP Library Granted Patent US 8,263,136
Granted Patent B2
US 8,263,136 · App. 13/208,812 · Granted Sep 11, 2012

Low dose colonic cleansing system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,136
App. No.
13/208,812
Granted
Sep 11, 2012
Kind
B2
Abstract

A method of colonic cleansing that includes administering orally a first dose and a second dose of a liquid osmotic colonic evacuant composition. The second dose includes an amount of the liquid osmotic colonic evacuant composition that is 55% to 95% of the amount of the first dose.

Claims (32)

1. A kit for colonic cleansing, comprising:

a first dose of an osmotic colonic evacuant composition, and

a second dose of the osmotic colonic evacuant composition,

wherein the second dose comprises an amount of the osmotic colonic evacuant composition that is 60% to 70% of the amount of the first dose of the osmotic colonic evacuant composition, and

the osmotic colonic evacuant is not in the form of tablets or capsules.

2. A kit of claim 1 , wherein the osmotic colonic evacuant composition comprises a phosphate cathartic.

3. The kit of claim 2 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate.

4. The kit of claim 3 , wherein the first dose of the phosphate cathartic comprises from 15 to 25 g monobasic sodium phosphate and from 5.5 to 9.4 g dibasic sodium phosphate.

5. The kit of claim 3 , wherein the first dose of the phosphate cathartic comprises 20 to 23 g monobasic sodium phosphate and 7.5 to 8.6 g dibasic sodium phosphate.

6. The kit of claim 3 , wherein the second dose of the phosphate cathartic comprises 12.96 to 15.12 g monobasic sodium phosphate and 4.86 to 5.67 g dibasic sodium phosphate.

7. The kit of claim 3 , wherein the phosphate cathartic comprises water.

8. The kit of claim 3 , wherein the first dose and the second dose of the phosphate cathartic are in a single sealed container.

9. The kit of claim 3 , wherein the first dose and the second dose of the phosphate cathartic are in separate sealed containers.

10. The kit of claim 3 , further comprising a flavorant and a sweetener.

11. The kit of claim 3 , wherein the phosphate cathartic comprises powder.

12. The kit of claim 11 , wherein the first dose and the second dose of the phosphate cathartic are in a single sealed container.

13. The kit of claim 11 , wherein the first dose and the second dose of the phosphate cathartic are in separate sealed containers.

14. The kit of claim 3 , further comprising a dosage container.

15. A kit for colonic cleansing, comprising:

an osmotic colonic evacuant composition; and

at least one dosage container,

wherein the at least one dosage container has markings to denote a first dose and a second dose, and

the second dose comprises an amount that is 60% to 70% of the amount of the first dose.

16. The kit of claim 15 , wherein osmotic colonic evacuant composition comprises a phosphate cathartic.

17. The kit of claim 15 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate.

18. A kit for colonic cleansing, comprising:

a first sealed container filled with 45 mL of an osmotic colonic evacuant composition;

a second sealed container filled with 30 mL of the osmotic colonic evacuant composition;

at least one packet comprising a flavorant; and

at least one dosage container;

wherein the osmotic colonic evacuant composition comprises 0.45 gram/mL of monobasic sodium phosphate and 0.18 gram/mL of dibasic sodium phosphate and

the at least one dosage container has at least one marking to denote a volume fill level.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 27, 2017
From: GOLUB CAPITAL MARKETS LLC (F/K/A GCI CAPITAL MARKETS LLC)
To: C. B. FLEET COMPANY, INC.; C.B. FLEET INVESTMENT CORPORATION
Reel/Frame 041102/0595 →
SECURITY INTEREST Recorded Oct 24, 2014
From: C. B. FLEET COMPANY, INCORPORATED; C.B. FLEET INVESTMENT CORPORATION
To: GCI CAPITAL MARKETS LLC, AS AGENT
Reel/Frame 034028/0363 →
RELEASE OF SECURITY INTEREST Recorded Oct 24, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: C. B. FLEET COMPANY, INCORPORATED
Reel/Frame 034032/0851 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 15, 2012
From: C. B. FLEET COMPANY, INCORPORATED
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 027873/0492 →